139 related articles for article (PubMed ID: 27337972)
1. Enzymatic and Inhibition Mechanism of Human Aromatase (CYP19A1) Enzyme. A Computational Perspective from QM/MM and Classical Molecular Dynamics Simulations.
Sgrignani J; Cavalli A; Colombo G; Magistrato A
Mini Rev Med Chem; 2016; 16(14):1112-24. PubMed ID: 27337972
[TBL] [Abstract][Full Text] [Related]
2. Computational approaches elucidate the allosteric mechanism of human aromatase inhibition: a novel possible route to Small-molecule regulation of CYP450s activities?
Sgrignani J; Bon M; Colombo G; Magistrato A
J Chem Inf Model; 2014 Oct; 54(10):2856-68. PubMed ID: 25178092
[TBL] [Abstract][Full Text] [Related]
3. Role of Water in the Puzzling Mechanism of the Final Aromatization Step Promoted by the Human Aromatase Enzyme. Insights from QM/MM MD Simulations.
Sgrignani J; Iannuzzi M; Magistrato A
J Chem Inf Model; 2015 Oct; 55(10):2218-26. PubMed ID: 26381712
[TBL] [Abstract][Full Text] [Related]
4. Molecular simulations of aromatase reveal new insights into the mechanism of ligand binding.
Park J; Czapla L; Amaro RE
J Chem Inf Model; 2013 Aug; 53(8):2047-56. PubMed ID: 23927370
[TBL] [Abstract][Full Text] [Related]
5. Insight into the enzyme-inhibitor interactions of the first experimentally determined human aromatase.
Punetha A; Shanmugam K; Sundar D
J Biomol Struct Dyn; 2011 Apr; 28(5):759-71. PubMed ID: 21294587
[TBL] [Abstract][Full Text] [Related]
6. Rational design of allosteric modulators of the aromatase enzyme: An unprecedented therapeutic strategy to fight breast cancer.
Spinello A; Martini S; Berti F; Pennati M; Pavlin M; Sgrignani J; Grazioso G; Colombo G; Zaffaroni N; Magistrato A
Eur J Med Chem; 2019 Apr; 168():253-262. PubMed ID: 30822713
[TBL] [Abstract][Full Text] [Related]
7. Influence of the membrane lipophilic environment on the structure and on the substrate access/egress routes of the human aromatase enzyme. A computational study.
Sgrignani J; Magistrato A
J Chem Inf Model; 2012 Jun; 52(6):1595-606. PubMed ID: 22621202
[TBL] [Abstract][Full Text] [Related]
8. Theoretical Study of the Mechanism of Exemestane Hydroxylation Catalyzed by Human Aromatase Enzyme.
Viciano I; Martí S
J Phys Chem B; 2016 Apr; 120(13):3331-43. PubMed ID: 26972150
[TBL] [Abstract][Full Text] [Related]
9. Recent developments in steroidal and nonsteroidal aromatase inhibitors for the chemoprevention of estrogen-dependent breast cancer.
Ahmad I; Shagufta
Eur J Med Chem; 2015 Sep; 102():375-86. PubMed ID: 26301554
[TBL] [Abstract][Full Text] [Related]
10. QM/MM modeling of the hydroxylation of the androstenedione substrate catalyzed by cytochrome P450 aromatase (CYP19A1).
Viciano I; Castillo R; Martí S
J Comput Chem; 2015 Sep; 36(23):1736-47. PubMed ID: 26096372
[TBL] [Abstract][Full Text] [Related]
11. Single or Multiple Access Channels to the CYP450s Active Site? An Answer from Free Energy Simulations of the Human Aromatase Enzyme.
Magistrato A; Sgrignani J; Krause R; Cavalli A
J Phys Chem Lett; 2017 May; 8(9):2036-2042. PubMed ID: 28423275
[TBL] [Abstract][Full Text] [Related]
12. The anti-epileptic drug lamotrigine inhibits the CYP17A1 lyase reaction in vitro.
Munkboel CH; Christensen LR; Islin J; Bonomo S; Olsen L; Jørgensen FS; Styrishave B
Biol Reprod; 2018 Oct; 99(4):888-897. PubMed ID: 29718108
[TBL] [Abstract][Full Text] [Related]
13. A Dehydrogenase Dual Hydrogen Abstraction Mechanism Promotes Estrogen Biosynthesis: Can We Expand the Functional Annotation of the Aromatase Enzyme?
Spinello A; Pavlin M; Casalino L; Magistrato A
Chemistry; 2018 Jul; 24(42):10840-10849. PubMed ID: 29770981
[TBL] [Abstract][Full Text] [Related]
14. Direct spectroscopic evidence for binding of anastrozole to the iron heme of human aromatase. Peering into the mechanism of aromatase inhibition.
Maurelli S; Chiesa M; Giamello E; Di Nardo G; Ferrero VE; Gilardi G; Van Doorslaer S
Chem Commun (Camb); 2011 Oct; 47(38):10737-9. PubMed ID: 21858332
[TBL] [Abstract][Full Text] [Related]
15. Aromatase inhibition by 2-methyl indole hydrazone derivatives evaluated via molecular docking and in vitro activity studies.
Ozcan-Sezer S; Ince E; Akdemir A; Ceylan ÖÖ; Suzen S; Gurer-Orhan H
Xenobiotica; 2019 May; 49(5):549-556. PubMed ID: 29804490
[TBL] [Abstract][Full Text] [Related]
16. Towards an Understanding of the Mode of Action of Human Aromatase Activity for Azoles through Quantum Chemical Descriptors-Based Regression and Structure Activity Relationship Modeling Analysis.
Chayawan C; Toma C; Benfenati E; Caballero Alfonso AY
Molecules; 2020 Feb; 25(3):. PubMed ID: 32046297
[TBL] [Abstract][Full Text] [Related]
17. Biochemical and computational insights into the anti-aromatase activity of natural catechol estrogens.
Neves MA; Dinis TC; Colombo G; Luisa Sá E Melo M
J Steroid Biochem Mol Biol; 2008 May; 110(1-2):10-7. PubMed ID: 18372170
[TBL] [Abstract][Full Text] [Related]
18. Insight into the binding interactions of CYP450 aromatase inhibitors with their target enzyme: a combined molecular docking and molecular dynamics study.
Galeazzi R; Massaccesi L
J Mol Model; 2012 Mar; 18(3):1153-66. PubMed ID: 21681442
[TBL] [Abstract][Full Text] [Related]
19. Development of a new class of aromatase inhibitors: design, synthesis and inhibitory activity of 3-phenylchroman-4-one (isoflavanone) derivatives.
Bonfield K; Amato E; Bankemper T; Agard H; Steller J; Keeler JM; Roy D; McCallum A; Paula S; Ma L
Bioorg Med Chem; 2012 Apr; 20(8):2603-13. PubMed ID: 22444875
[TBL] [Abstract][Full Text] [Related]
20. Working at the membrane interface: Ligand-induced changes in dynamic conformation and oligomeric structure in human aromatase.
Di Nardo G; Cimicata G; Baravalle R; Dell'Angelo V; Ciaramella A; Catucci G; Ugliengo P; Gilardi G
Biotechnol Appl Biochem; 2018 Jan; 65(1):46-53. PubMed ID: 28926141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
